Endoscopic management of malignant biliary obstruction by means of covered metallic stents: primary stent placement vs. re-intervention

Background and study aims: Recent progress in chemotherapy has prolonged the survival of patients with malignant biliary strictures, leading to increased rates of stent occlusion. Occlusion of covered metallic stents now occurs in about half of all patients with malignant biliary strictures. The removal of metallic stents followed by placement of a second stent has been attempted, but outcomes remain controversial. The aim of the current study was to evaluate the effectiveness and safety of the primary placement and secondary placement (re-intervention) of covered metallic stents and to assess the feasibility and safety of stent removal. Patients and methods: The study included 186 patients with unresectable malignant biliary strictures who underwent primary stent placement between October 2001 and March 2010. Covered biliary self-expandable metal stents (SEMSs) were removed in 39 of these patients, and 36 underwent re-intervention. The patency times, occlusion rates of the first stent and re-intervention, success rates of stent removal, and complications were investigated. Results: Covered SEMSs were placed in 186 patients. The median patency time of the first stent was 352 days. Stent occlusion occurred in 48.9 % of the patients and was mainly caused by debris or food residue (37 %), dislocation (19 %), and migration with hyperplasia (19 %). Stent removal was attempted in 50 patients and was successful without complication in 39 (78 %). Most of the patients in whom stent removal was unsuccessful had migration with hyperplasia. The median patency time of the second stent was 263 days. The stent patency time did not significantly differ between the first and the second stent. Conclusions: Covered SEMSs could be safely removed at the time of stent occlusion. Patency rates were similar for initial stent placement and re-intervention.

[1]  C. Thompson,et al.  A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. , 2010, Gastrointestinal endoscopy.

[2]  E. Jonas,et al.  Covered versus uncovered self- expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study , 2010, Journal of Digestive Endoscopy.

[3]  D. Cunningham,et al.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. , 2010, The New England journal of medicine.

[4]  R. Chuttani,et al.  Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention. , 2009, Gastrointestinal endoscopy.

[5]  M. Highley,et al.  Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study , 2009, British Journal of Cancer.

[6]  P. Murawa,et al.  Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Kongkam,et al.  Trimming a Metallic Biliary Stent Using an Argon Plasma Coagulator , 2007, CardioVascular and Interventional Radiology.

[8]  D. Seo,et al.  Endoscopic removal of biliary self-expandable metallic stents: a prospective study. , 2006, Endoscopy.

[9]  R. Shah,et al.  Safety and Efficacy of Argon Plasma Coagulation Trimming of Malpositioned and Migrated Biliary Metal Stents: A Controlled Study in the Porcine Model , 2006, The American Journal of Gastroenterology.

[10]  K. Lee,et al.  A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. , 2006, Gastrointestinal endoscopy.

[11]  J. Kim,et al.  Covered versus uncovered wallstent for malignant extrahepatic biliary obstruction: a cohort comparative analysis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  Linda S. Lee,et al.  Endoscopic removal of malfunctioning biliary self-expandable metallic stents. , 2005, Gastrointestinal endoscopy.

[13]  F. Caroli-Bosc,et al.  Endoscopic argon plasma trimming of biliary and gastrointestinal metallic stents. , 2005, Endoscopy.

[14]  J. Tokar,et al.  Removal of self-expandable metallic Wallstents. , 2004, Gastrointestinal endoscopy.

[15]  G. Costamagna,et al.  Endoscopic Stenting for Biliary and Pancreatic Malignancies , 2004, Journal of clinical gastroenterology.

[16]  A. Poulos,et al.  Treatment of Metallic Biliary Stent-Induced Duodenal Ulceration Using Endoscopic Laser Therapy , 2004, Digestive Diseases and Sciences.

[17]  R. Kurtz,et al.  Endoscopic management of occluded biliary Wallstents: a cancer center experience. , 2003, Gastrointestinal endoscopy.

[18]  G. Elta,et al.  Migration of covered biliary self-expanding metallic stents in two patients with malignant biliary obstruction. , 2003, Gastrointestinal endoscopy.

[19]  M. Levy,et al.  Endoscopic Removal of a Biliary Wallstent with a Suture-Cutting Device in a Patient with Primary Pancreatic Lymphoma , 2002, Endoscopy.

[20]  C. Wilcox,et al.  Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis , 2002, American Journal of Gastroenterology.

[21]  P. Rampal,et al.  Argon Plasma Endoscopic Section of Biliary Metallic Prostheses , 2001, Endoscopy.

[22]  T. Baron,et al.  Endoscopic removal of an embedded biliary Wallstent by piecemeal extraction. , 2000, Endoscopy.

[23]  E. Keeffe,et al.  A novel technique for endoscopic removal of expandable biliary Wallstent. , 1999, Gastrointestinal endoscopy.

[24]  J. van Dam,et al.  Management of occluded biliary Wallstents , 1998, Gut.

[25]  D. V. Von Hoff,et al.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  W. Reichel,et al.  Malignant bile-duct obstruction: experience with self-expanding metal endoprostheses (Wallstents) in Austria. , 1994, Endoscopy.

[27]  J. Pausch,et al.  A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. , 1993, Endoscopy.

[28]  P. Fockens,et al.  Endoscopic Placement of Expandable Metal Stents for Biliary Strictures - A Preliminary Report on Experience with 33 Patients , 1989, Endoscopy.

[29]  M. Classen,et al.  Self-expanding Biliary Stents: Preliminary Clinical Experience , 1989, Endoscopy.

[30]  G. Tytgat,et al.  Transpapillary positioning of a large 3.2 mm biliary endoprosthesis. , 1981, Endoscopy.